Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'- dideoxynucleosides

doi:10.1084/jem.168.3.1111

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Perno, C. F.
	Articles by Johns, D. G.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Perno, C. F.
	Articles by Johns, D. G.


Social Bookmarking

	What's this?

ARTICLES

Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'- dideoxynucleosides

CF Perno, R Yarchoan, DA Cooney, NR Hartman, S Gartner, M Popovic, Z Hao, TL Gerrard, YA Wilson and DG Johns
Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland 20892.

Because of the probable role of HIV-infected monocyte/macrophages in the pathogenesis and progression of AIDS, it is essential that antiretroviral therapy address viral replication in cells of this lineage. Several dideoxynucleosides have been shown to have potent in vitro and, in the case of 3'-azido-2',3'-dideoxythymidine (AZT) and 2',3'-dideoxycytidine (ddC), in vivo activity against HIV. However, because these compounds must be phosphorylated (activated) in target cells, and because monocyte/macrophages may have levels of kinases that differ from those in lymphocytes, we investigated the capacity of these drugs to suppress HIV replication in monocyte/macrophages using HIV- 1/HTLV-IIIBa-L (a monocytotropic isolate). In the present study, we observed that HTLV-IIIBa-L replication in fresh human peripheral blood monocyte/macrophages was suppressed by each of three dideoxynucleosides: 3'-azido-2',3'-dideoxythymidine (AZT), 2',3'- dideoxycytidine (ddC), and 2',3'-dideoxyadenosine (ddA). Similar results were observed in 5-d-cultured monocyte/macrophages, although higher concentrations of the drugs were required. We then studied the metabolism of AZT and ddC in such cells. The phosphorylation of ddC to a triphosphate moiety was somewhat decreased in monocyte/macrophages as compared with H9 T cells. On the other hand, the phosphorylation of AZT in monocyte/macrophages was markedly decreased to 25% or less of the level in T cells. However, when we examined the level of the normal endogenous 2'-deoxynucleoside triphosphate pools, which compete with 2',3'-dideoxynucleoside triphosphate for viral reverse transcriptase, we found that the level of 2'-deoxycytidine-triphosphate (dCTP) was six- to eightfold reduced, and that of 2'-deoxythymidine-triphosphate (dTTP) was only a small fraction of that found in T cell lines. These results suggest that the ratio of dideoxynucleoside triphosphate to normal deoxynucleoside triphosphate is a crucial factor in determining the antiviral activity of dideoxynucleosides in HIV target cells, and that the lower levels of dTTP may account for the antiretroviral activity of AZT in the face of inefficient phosphorylation of this compound.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Perez-Bercoff, D., Wurtzer, S., Compain, S., Benech, H., Clavel, F. (2007). Human Immunodeficiency Virus Type 1: Resistance to Nucleoside Analogues and Replicative Capacity in Primary Human Macrophages. J. Virol. 81: 4540-4550 [Abstract] [Full Text]
Rossi, L., Franchetti, P., Pierige, F., Cappellacci, L., Serafini, S., Balestra, E., Perno, C.-F., Grifantini, M., Calio, R., Magnani, M. (2007). Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir. J Antimicrob Chemother 59: 666-675 [Abstract] [Full Text]
Aquaro, S., Svicher, V., Schols, D., Pollicita, M., Antinori, A., Balzarini, J., Perno, C. F. (2006). Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies. J. Leukoc. Biol. 80: 1103-1110 [Abstract] [Full Text]
Slish, J. C., Catanzaro, L. M., Okusanya, O., Demeter, L. M., Albrecht, M., Difrancesco, R., Morse, G. D. (2005). Therapeutic Drug Monitoring: Role for a Pharmacist in Multidisciplinary Antiretroviral Management. Journal of Pharmacy Practice 18: 310-321 [Abstract]
Aquaro, S., Svicher, V., Ceccherini-Silberstein, F., Cenci, A., Marcuccilli, F., Giannella, S., Marcon, L., Calio, R., Balzarini, J., Perno, C.-F. (2005). Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages. J Antimicrob Chemother 55: 872-878 [Abstract] [Full Text]
Magnani, M., Balestra, E., Fraternale, A., Aquaro, S., Paiardini, M., Cervasi, B., Casabianca, A., Garaci, E., Perno, C.-F. (2003). Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression. J. Leukoc. Biol. 74: 764-771 [Abstract] [Full Text]
Williams, K., Schwartz, A., Corey, S., Orandle, M., Kennedy, W., Thompson, B., Alvarez, X., Brown, C., Gartner, S., Lackner, A. (2002). Proliferating Cellular Nuclear Antigen Expression as a Marker of Perivascular Macrophages in Simian Immunodeficiency Virus Encephalitis. Am. J. Pathol. 161: 575-585 [Abstract] [Full Text]
Alfano, M., Vallanti, G., Biswas, P., Bovolenta, C., Vicenzi, E., Mantelli, B., Pushkarsky, T., Rappuoli, R., Lazzarin, A., Bukrinsky, M., Poli, G. (2001). The Binding Subunit of Pertussis Toxin Inhibits HIV Replication in Human Macrophages and Virus Expression in Chronically Infected Promonocytic U1 Cells. J. Immunol. 166: 1863-1870 [Abstract] [Full Text]
D'Cruz, O. J., Venkatachalam, T. K., Uckun, F. M. (2001). Thymidine Kinase-Independent Intracellular Delivery of Bioactive Nucleotides by Aryl Phosphate Derivatives of Bromo-Methoxy Zidovudine (Compounds WHI-05 and WHI-07) in Normal Human Female Genital Tract Epithelial Cells and Sperm. Biol. Reprod. 64: 51-59 [Abstract] [Full Text]
Igarashi, T., Brown, C. R., Endo, Y., Buckler-White, A., Plishka, R., Bischofberger, N., Hirsch, V., Martin, M. A. (2000). Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc. Natl. Acad. Sci. USA 10.1073/pnas.021551798v1 [Abstract] [Full Text]
Aquaro, S., Panti, S., Caroleo, M. C., Balestra, E., Cenci, A., Forbici, F., Ippolito, G., Mastino, A., Testi, R., Mollace, V., Calio, R., Perno, C. F. (2000). Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes. J. Leukoc. Biol. 68: 429-435 [Abstract] [Full Text]
Aquaro, S., Wedgwood, O., Yarnold, C., Cahard, D., Pathinara, R., McGuigan, C., Calio', R., de Clercq, E., Balzarini, J., Perno, C. F. (2000). Activities of Masked 2',3'-Dideoxynucleoside Monophosphate Derivatives against Human Immunodeficiency Virus in Resting Macrophages. Antimicrob. Agents Chemother. 44: 173-177 [Abstract] [Full Text]
Balzarini, J., Naesens, L., Aquaro, S., Knispel, T., Perno, C.-F., De Clercq, E., Meier, C. (1999). Intracellular Metabolism of CycloSaligenyl 3'-Azido-2',3'-dideoxythymidine Monophosphate, a Prodrug of 3'-Azido-2',3'-dideoxythymidine (Zidovudine). Mol. Pharmacol. 56: 1354-1361 [Abstract] [Full Text]
Raskino, C., Pearson, D. A., Baker, C. J., Lifschitz, M. H., O'Donnell, K., Mintz, M., Nozyce, M., Brouwers, P., McKinney, R. E., Jimenez, E., Englund, J. A., for the Pediatric AIDS Clinical Trials Group 152 S, (1999). Neurologic, Neurocognitive, and Brain Growth Outcomes in Human Immunodeficiency Virus-Infected Children Receiving Different Nucleoside Antiretroviral Regimens. Pediatrics 104 : e32-e32 [Abstract] [Full Text]
Mitsuya, H, Yarchoan, R, Broder, S (1990). Molecular targets for AIDS therapy. Science 249: 1533-1544 [Abstract]
Igarashi, T., Brown, C. R., Endo, Y., Buckler-White, A., Plishka, R., Bischofberger, N., Hirsch, V., Martin, M. A. (2001). Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc. Natl. Acad. Sci. USA 98: 658-663 [Abstract] [Full Text]